Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Colchicine Use Is Associated with Shorter ICU Stay and Lower FFP Transfusion Requirements After CABG
Mehmet Burak Gulcan; Mehmet Ali Kaygın; Aycan Mutlu Yaganoglu; Ziya Yıldız; Abdulselam Karaduman; Suleyman Aycan; Ozgur DagShow moreShow less
1. Department of Cardiovascular Surgery, Ankara Yıldırım Beyazıt University Yenimahalle Training and Research Hospital, 06370 Ankara, Türkiye; 2. Department of Cardiovascular Surgery, Erzurum City Hospital, 25240 Erzurum, Türkiye; 3. Department of Zootechnics, Faculty of Agriculture, Ataturk University , 25240 Erzurum, Türkiye; 4. Department of Congenital Cardiovascular Surgery, Mehmet Akif Ersoy Chest and Cardiovascular Surgery Research and Training Hospital, 34303 Istanbul, TürkiyeShow moreShow less
Development and Population-Based Prognostic Utility Assessment of an ICD-10-CM-Based Prediction Model to Identify Left Ventricular Systolic Dysfunction: Discrimination Performance and Population-Based Evaluation in 83,357 Patients with Acute Coronary Syndrome
Andreea Eunice Cosa; Marc Llagostera Martin; Sílvia Jovells-Vaqué; Mireia Andrés-Villareal; Emili Vela; Júlia Folguera Profitós; David Monterde; Jordi Piera-Jiménez; Gerard Carot-Sans; Raúl Ramos-Polo; Oona Meroño; Adrià Ricarte Marín; Natalia López Fernández; Albert Ariza-Solé; Cristina Enjuanes; Josep Comín-ColetShow moreShow less
1. Bio-Heart Cardiovascular Diseases Research Group, https://ror.org/0008xqs48Bellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain; aeunice@idibell.cat (A.E.C.); sjovells@idibell.cat (S.J.-V.); mireia.andres.idi@gencat.cat (M.A.-V.); rramosp@bellvitgehospital.cat (R.R.-P.); cenjuanes@bellvitgehospital.cat (C.E.); 2. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto Salud Carlos III, 28029 Madrid, Spain; 3. Cardiology Department, Heart Institute, https://ror.org/00epner96Bellvitge University Hospital, 08907 Barcelona, Spain; mllagosteram@bellvitgehospital.cat (M.L.M.); omerono@bellvitgehospital.cat (O.M.); aariza@bellvitgehospital.cat (A.A.-S.); 4. Gerència d’Atenció Primària i Comunitària (GAPiC) Delta and Penedès, Catalan Health Institute, 08907 Barcelona, Spain; 5. Medicine Department, School of Medicine, https://ror.org/00tse2b39International University of Catalonia, 08195 Barcelona, Spain; 6. Health Information System Department, Catalan Health Service, 08007 Barcelona, Spain; evela@catsalut.cat (E.V.); julia.folguera@catsalut.cat (J.F.P.); gerard.carot@catsalut.cat (G.C.-S.); 7. Digitalization for the Sustainability of the Healthcare System (DS3), 08006 Barcelona, Spain; dmonterde@gencat.cat (D.M.); jpiera@catsalut.cat (J.P.-J.); 8. Health Information System Department, Catalan Institute of Health, 08007 Barcelona, Spain; 9. Fundació TIC Salut i Social, 08009 Barcelona, Spain; 10. Community Heart Failure Program, Cardiology Department, https://ror.org/00epner96Bellvitge University Hospital, 08907 Barcelona, Spain; 11. Functional Data Management Unit, https://ror.org/00epner96Bellvitge University Hospital, 08907 Barcelona, Spain; aricarte@bellvitgehospital.cat (A.R.M.); natalialopez@bellvitgehospital.cat (N.L.F.); 12. Department of Clinical Sciences, School of Medicine, Universitat de Barcelona, 08907 Barcelona, SpainShow moreShow less
Coexisting Moderate-to-Severe Tricuspid Regurgitation and Renal Dysfunction Identify a High-Risk Group After Transcatheter Aortic Valve Replacement
Philipp Lauten; Birgit Markus; Georgios Chatzis; Styliani Syntila; Bernhard Schieffer; Klevis Mihali; Julian KreutzShow moreShow less
1. Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps-Universität Marburg, Baldingerstraße, 35043 Marburg, Germany; 2. Department of Cardiology, Heart Center, Central Hospital of Bad Berka, 99437 Bad Berka, GermanyShow moreShow less
Recurrence Rates and Outcomes After First Detected Atrial Fibrillation Episode in a Contemporary Hypertrophic Cardiomyopathy Center
Mauro Rogerio de Barros Wanderley; Martin S. Maron; Jonathan S. Silver; Paul Harnish; Bruce G. Hook; Ethan J. RowinShow moreShow less
1. Internal Medicine Department, https://ror.org/03mbq3y29Lahey Hospital and Medical Center, Burlington, MA 01803, USA; mdebarr2@lahey.org; 2. Hypertrophic Cardiomyopathy Center, https://ror.org/03mbq3y29Lahey Hospital and Medical Center, Burlington, MA 01803, USA; 3. Department of Electrophysiology, https://ror.org/03mbq3y29Lahey Hospital and Medical Center, Burlington, MA 01803, USAShow moreShow less
Machine Learning-Based Prediction of Long-Term Mortality in Patients with Implantable Cardioverter Defibrillators
Lei Pan; Zilong Xiao; Ziqing Yu; Siyuan Li; Weiwei Zhang; Ruogu Li; Zhongkai Wang; Hongyang Lu; Wei Hua; Yangang Su; Yixiu LiangShow moreShow less
1. Department of Cardiology, https://ror.org/032x22645Zhongshan Hospital of Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Centre for Interventional Medicine, Shanghai 200032, China; panleiyaomingkaka@126.com (L.P.); xiao1453497595@163.com (Z.X.); yu.ziqing@zs-hospital.sh.cn (Z.Y.);; 2. Shanghai Medical College, https://ror.org/013q1eq08Fudan University, Shanghai 200032, China; lisiyuan24@m.fudan.edu.cn; 3. Department of Cardiology, Shanghai Chest Hospital of https://ror.org/0220qvk04Shanghai Jiao Tong University, Shanghai 200030, China; zww1230523@163.com (W.Z.); liruogu@hotmail.com (R.L.); 4. Department of Cardiology, https://ror.org/02bjs0p66Changhai Hospital, Naval Medical University, Shanghai 200433, China; 13816038626@163.com; 5. Cardiac Rhythm Management, Medtronic Technology Center, Medtronic (Shanghai) Ltd., Shanghai 201203, China; 6. State Key Laboratory of Cardiovascular Disease, Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, https://ror.org/02drdmm93Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China; drhuaweifw@sina.comShow moreShow less
Preoperative Advanced Lung Cancer Inflammation Index and Acute Kidney Injury After Adult Cardiac Surgery: A Retrospective Cohort Study
Haoran Gan; Ruoyu Zhang; Rui Fan; Li Yin; Shengjie Ning; Junzhe Wang; Dongming Liu; Wen Chen; Xin Chen; Zhibing QiuShow moreShow less
1. Department of Thoracic and Cardiovascular Surgery, Nanjing First Hospital, Nanjing University of Chinese Medicine, Nanjing 210006, China; 2. Department of Thoracic and Cardiovascular Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, ChinaShow moreShow less
FAQ
How long does Journal of Cardiovascular Development and Disease take to review a manuscript?
As of 2026-11-19, CrushSCI has 10 complete review records for Journal of Cardiovascular Development and Disease. The fastest paper went from submission to acceptance in 13 days (Evaluation of Clinical SYNTAX Score in Predicting New-Onset Atrial Fibrillation and Long-Term Prognosis in Patients Hospitalized with Non-ST Segment Elevation Myocardial Infarction, received 2026-09-14, accepted 2026-09-27); the slowest took 104 days. The average is 37.8 days and the median is 33.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
